01:44 PM EDT, 05/30/2025 (MT Newswires) -- Health care stocks advanced Friday afternoon with the NYSE Health Care Index up 0.7% and the Health Care Select Sector SPDR Fund (XLV) adding 0.1%.

The iShares Biotechnology ETF (IBB) fell 2.4%.

In corporate news, Bioline RX ( BLRX ) shares jumped 32% after the company said results from a phase 2 trial of motixafortide to treat pancreatic cancer, along with cemiplimab and standard-of-care chemotherapies, showed that four out of 11 patients remained progression-free after more than one year.